Entutech, BTS Character TinyTAN Collaboration Synergy Accelerates 'Expectations'

[Asia Economy Reporter Hyunseok Yoo] Nano mask specialist company N2TEC announced on the 29th that its affiliate N2CELL has launched the ‘BREATH SILVER TinyTAN’ mask, featuring BTS character ‘TinyTAN’ on the packaging (mask).

N2TEC signed a supply contract worth 152 billion KRW with N2CELL and is currently producing nano masks at its factory in Paju, Gyeonggi Province. They have completed the establishment of nano mask production facilities capable of producing up to 4 million masks per day and up to 100 million masks per month. In particular, ‘BREATH SILVER’ recently obtained certifications from the U.S. Food and Drug Administration (FDA) and the European CE (European Community Mark). The company explained that with preparations for global supply complete, synergy effects with TinyTAN are expected. N2TEC is currently negotiating orders worth hundreds of millions of masks with countries in Europe and Southeast Asia.

The mask brand ‘BREATH SILVER’, launched in 2017, is a high-performance mask equipped with an ultrafine nanofiber filter with a PM 0.1 diameter. It applies the antibacterial composite capsule ‘SSNC’, registered with the U.S. Environmental Protection Agency (EPA), which blocks more than 650 types of harmful bacteria. Unlike conventional electrostatic masks whose filter efficiency deteriorates due to internal moisture during long-term wear, it uses the ultrafine nanofiber filter ‘BREAXELL’ with a PM 0.1 diameter to filter ultrafine dust physically without electrostatic assistance, maintaining efficiency continuously.

N2CELL plans to launch BREATH SILVER TinyTAN globally next month in the U.S., Japan, Thailand, Hong Kong, Taiwan, the Middle East, and other regions. Additionally, they plan to introduce mask necklaces and antibacterial pouches featuring ‘TinyTAN’. A N2TEC official said, “Since the acquisition and merger of drama production company Ace Factory, the results of business diversification have begun to materialize. After entering the mask business, we secured an order backlog worth 152 billion KRW, and with the synergy effect of collaboration between N2CELL and BTS, the order volume is expected to increase further.” He added, “After recruiting Dr. Robert Langer and Mr. Ian Chen, founding members and major shareholders of U.S. COVID-19 vaccine developer Moderna, as executives, we will strive to achieve rapid results in the vaccine distribution business as well.”